Mwandishi:
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
1 Agosti 2026, 07:32:03
Acute cystitis (lower urinary tract infection)
Acute cystitis is an infection of the lower urinary tract involving the urinary bladder and, in some cases, the urethra. It is the most common form of urinary tract infection (UTI) and occurs predominantly in women due to their shorter urethra and proximity of the urethral opening to the perineum. Acute cystitis may be classified as uncomplicated or complicated. Uncomplicated cystitis occurs in healthy, non-pregnant women of reproductive age with no structural or functional abnormalities of the urinary tract. Complicated cystitis occurs in all other patient groups, including men, pregnant women, children, elderly individuals, and patients with urinary tract abnormalities or immunocompromising conditions.
The most common causative organisms are Escherichia coli, followed by Klebsiella pneumoniae, Proteus species, and Staphylococcus aureus.
Epidemiology
Acute cystitis is one of the most common bacterial infections worldwide. Women are significantly more affected than men, with more than half of women experiencing at least one UTI during their lifetime. Recurrence is common, particularly among sexually active women and individuals with underlying urinary tract abnormalities.
Risk factors
General risk factors
Female sex
Sexual activity
Previous urinary tract infection
Pregnancy
Diabetes mellitus
Urinary tract obstruction
Urinary stones
Vesicoureteric reflux
Neurogenic bladder
Urinary catheterization
Immunosuppression
Poor perineal hygiene
Incomplete bladder emptying
Menopause
Pathophysiology
Acute cystitis usually results from ascending bacterial infection. Organisms colonize the periurethral area and ascend through the urethra into the bladder. Bacterial adherence to the urothelium triggers inflammation, leading to mucosal oedema, hyperaemia, and irritation of the bladder wall.
Inflammation of the bladder mucosa produces the characteristic symptoms of dysuria, frequency, urgency, and suprapubic discomfort. If left untreated, infection may ascend to involve the upper urinary tract, resulting in pyelonephritis.
Clinical presentation
Acute cystitis typically presents with localized lower urinary tract symptoms without significant systemic illness.
Symptoms
Dysuria
Urinary frequency
Urinary urgency
Suprapubic pain
Suprapubic discomfort
Burning sensation during micturition
Nocturia
Haematuria
Cloudy urine
Foul-smelling urine
Clinical signs
Suprapubic tenderness
Mild lower abdominal tenderness
Pyuria
Occasionally haematuria
Temperature of 38°C or higher in some patients
Systemic features such as flank pain, severe fever, rigors, or vomiting should raise suspicion for upper urinary tract infection.
Diagnostic criteria
The diagnosis of acute cystitis is based on:
Presence of urinary symptoms such as dysuria, frequency, and urgency
Evidence of pyuria on urinalysis or urine microscopy
Positive urine culture when available
Diagnosis is strongly supported by:
Positive leukocyte esterase
Positive nitrite test
More than 8–10 white blood cells per high-power field on urine microscopy
Significant bacterial growth on urine culture
Investigations
Urinalysis
Leukocyte esterase
Nitrite test
Protein
Glucose
Urinary pH
Urine microscopy
White blood cells
Red blood cells
Bacteria
Urine culture and antimicrobial susceptibility testing
Urine culture is recommended in:
Recurrent infections
Complicated infections
Treatment failure
Pregnancy
Suspected antimicrobial resistance
Additional investigations
Where indicated:
Full blood count
Serum creatinine
Blood glucose
Renal ultrasound in recurrent or complicated infections
Management
The objectives of treatment are symptom relief, eradication of infection, prevention of recurrence, and prevention of complications such as pyelonephritis.
Non-pharmacological treatment
Encourage adequate oral fluid intake
Encourage regular bladder emptying
Advise urination whenever the urge to void occurs
Encourage urination after sexual intercourse
Maintain good perineal hygiene
Avoid unnecessary urinary catheterization
Remove indwelling urinary catheters where appropriate
Pharmacological treatment
Analgesia for severe dysuria
Adults
Paracetamol 500–1000 mg orally every 6–8 hours when required.
Children
Paracetamol 15 mg/kg/dose orally every 4–6 hours when required, up to a maximum of 4 doses in 24 hours.
Uncomplicated cystitis
Adults
Nitrofurantoin 100 mg orally every 12 hours for 5 days.
OR
Flucloxacillin + amoxicillin (fixed-dose combination) 500 mg orally every 8 hours for 5 days.
Complicated cystitis
Adults
Ciprofloxacin 500 mg orally every 12 hours for 7 days.
OR
Amoxicillin + clavulanic acid (fixed-dose combination) 625 mg orally every 12 hours for 7 days.
Pregnant women and adolescents
Nitrofurantoin 100 mg orally every 12 hours for 5 days.
OR
Amoxicillin + clavulanic acid (fixed-dose combination) 625 mg orally every 12 hours for 7 days.
Children
Nitrofurantoin 50 mg orally every 12 hours for 5 days.
Nitrofurantoin should not be used in children with glucose-6-phosphate dehydrogenase (G6PD) deficiency or porphyria.
OR
Amoxicillin + clavulanic acid 40 mg/kg/day (calculated as the amoxicillin component) orally in three divided doses for 7 days, up to a maximum of 2000 mg amoxicillin daily.
Management according to underlying cause
Catheter-associated infection
Remove or replace the catheter where appropriate.
Treat according to urine culture and sensitivity results.
Urinary tract obstruction
Treat infection promptly.
Relieve obstruction and refer for definitive management.
Diabetes mellitus
Optimize glycaemic control.
Monitor for recurrent infection and complications.
Recurrent cystitis
Investigate for urinary tract abnormalities.
Consider specialist referral.
Referral
Refer the patient if:
Symptoms persist despite appropriate treatment
Recurrent urinary tract infections occur
Urinary tract obstruction is suspected
Urinary stones are suspected
Significant haematuria is present
Pregnancy is complicated by recurrent infection
Renal impairment is present
The diagnosis is uncertain
There is suspicion of pyelonephritis or urosepsis
Complications
Acute pyelonephritis
Recurrent urinary tract infection
Renal abscess
Urosepsis
Chronic urinary symptoms
Renal scarring in recurrent infections
Adverse pregnancy outcomes
Prognosis
The prognosis is excellent with prompt diagnosis and appropriate antimicrobial therapy. Most patients experience complete symptom resolution within a few days of treatment. Delayed treatment, antimicrobial resistance, or underlying urinary tract abnormalities increase the risk of recurrence and complications.
Prevention
Adequate fluid intake
Good personal hygiene
Urination after sexual intercourse
Avoid prolonged urinary retention
Appropriate management of diabetes mellitus
Prompt treatment of urinary symptoms
Avoid unnecessary catheterization
Early removal of urinary catheters
Investigation and correction of structural urinary tract abnormalities where possible
Imeandikwa:
25 Mei 2026, 16:57:39
Rejea za mada hii:
Ministry of Health, Community Development, Gender, Elderly and Children. Standard Treatment Guidelines and National Essential Medicines List for Tanzania Mainland. 6th ed. Dodoma: Ministry of Health; 2021.
European Association of Urology. EAU Guidelines on Urological Infections. Arnhem: EAU Guidelines Office; 2025.
Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women. Clin Infect Dis. 2011;52(5):e103-e120.
Bonkat G, Bartoletti R, Bruyère F, Cai T, Geerlings SE, Köves B, et al. EAU guidelines on urological infections. Eur Urol. 2025.
World Health Organization. Integrated management of adolescent and adult illness: District clinician manual. Geneva: World Health Organization; 2021.
Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 21st ed. New York: McGraw-Hill Education; 2022.
